{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Oregovomab",
  "nciThesaurus": {
    "casRegistry": "213327-37-8",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A murine monoclonal antibody that attaches to the tumor-associated antigen CA125. Vaccination with monoclonal antibody B43.13 may stimulate a host cytotoxic immune response against tumor cells that express CA125.",
    "fdaUniiCode": "HX101E7L6S",
    "identifier": "C1784",
    "preferredName": "Oregovomab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C20401"
    ],
    "synonyms": [
      "B43.13",
      "MoAb B43.13",
      "Monoclonal Antibody B43.13",
      "OREGOVOMAB",
      "Oregovomab",
      "OvaRex",
      "OvaRex Monoclonal Antibody B43.13",
      "oregovomab"
    ]
  }
}